186 related articles for article (PubMed ID: 27566654)
1. EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.
Johnson C; Segovia B; Kandpal RP
Cancer Genomics Proteomics; 2016 09-10; 13(5):359-68. PubMed ID: 27566654
[TBL] [Abstract][Full Text] [Related]
2. A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines.
Fox BP; Kandpal RP
Cancer Genomics Proteomics; 2011; 8(4):185-93. PubMed ID: 21737611
[TBL] [Abstract][Full Text] [Related]
3. Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells.
Zadeh T; Lucero M; Kandpal RP
Cancer Genomics Proteomics; 2022; 19(1):19-26. PubMed ID: 34949656
[TBL] [Abstract][Full Text] [Related]
4. Modulation of liver-intestine cadherin (Cadherin 17) expression, ERK phosphorylation and WNT signaling in EPHB6 receptor-expressing MDA-MB-231 cells.
Bhushan L; Tavitian N; Dey D; Tumur Z; Parsa C; Kandpal RP
Cancer Genomics Proteomics; 2014; 11(5):239-49. PubMed ID: 25331796
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase-deficient EphB6 receptor-dependent alterations in proteomic profiles of invasive breast carcinoma cells as determined by difference gel electrophoresis.
Kandpal RP
Cancer Genomics Proteomics; 2010; 7(5):253-60. PubMed ID: 20952760
[TBL] [Abstract][Full Text] [Related]
6. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
[TBL] [Abstract][Full Text] [Related]
7. Dancing with the dead: Eph receptors and their kinase-null partners.
Truitt L; Freywald A
Biochem Cell Biol; 2011 Apr; 89(2):115-29. PubMed ID: 21455264
[TBL] [Abstract][Full Text] [Related]
8. EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells.
Fox BP; Kandpal RP
Oncogene; 2009 Apr; 28(14):1706-13. PubMed ID: 19234485
[TBL] [Abstract][Full Text] [Related]
9. Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.
Nagano K; Maeda Y; Kanasaki S; Watanabe T; Yamashita T; Inoue M; Higashisaka K; Yoshioka Y; Abe Y; Mukai Y; Kamada H; Tsutsumi Y; Tsunoda S
J Control Release; 2014 Sep; 189():72-9. PubMed ID: 24946238
[TBL] [Abstract][Full Text] [Related]
10. EphB6 receptor modulates micro RNA profile of breast carcinoma cells.
Bhushan L; Kandpal RP
PLoS One; 2011; 6(7):e22484. PubMed ID: 21811619
[TBL] [Abstract][Full Text] [Related]
11. The intracellular domains of the EphB6 and EphA10 receptor tyrosine pseudokinases function as dynamic signalling hubs.
Liang LY; Roy M; Horne CR; Sandow JJ; Surudoi M; Dagley LF; Young SN; Dite T; Babon JJ; Janes PW; Patel O; Murphy JM; Lucet IS
Biochem J; 2021 Sep; 478(17):3351-3371. PubMed ID: 34431498
[TBL] [Abstract][Full Text] [Related]
12. Isoform expression patterns of EPHA10 protein mediate breast cancer progression by regulating the E-Cadherin and β-catenin complex.
Li Y; Jin L; Ye F; Ma Q; Yang Z; Liu D; Yang J; Ma D; Gao Q
Oncotarget; 2017 May; 8(18):30344-30356. PubMed ID: 28427223
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration.
Peng J; Zhang D
J Investig Med; 2021 Aug; 69(6):1215-1221. PubMed ID: 33990369
[TBL] [Abstract][Full Text] [Related]
14. Ligand stimulation induces clathrin- and Rab5-dependent downregulation of the kinase-dead EphB6 receptor preceded by the disruption of EphB6-Hsp90 interaction.
Allonby O; El Zawily AM; Freywald T; Mousseau DD; Chlan J; Anderson D; Benmerah A; Sidhu V; Babu M; DeCoteau J; Freywald A
Cell Signal; 2014 Dec; 26(12):2645-57. PubMed ID: 25152371
[TBL] [Abstract][Full Text] [Related]
15. Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.
Brantley-Sieders DM; Jiang A; Sarma K; Badu-Nkansah A; Walter DL; Shyr Y; Chen J
PLoS One; 2011; 6(9):e24426. PubMed ID: 21935409
[TBL] [Abstract][Full Text] [Related]
16. Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application.
Fox BP; Kandpal RP
Biochem Biophys Res Commun; 2004 Jun; 318(4):882-92. PubMed ID: 15147954
[TBL] [Abstract][Full Text] [Related]
17. Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Nagano K; Yamashita T; Inoue M; Higashisaka K; Yoshioka Y; Abe Y; Mukai Y; Kamada H; Tsutsumi Y; Tsunoda S
Biochem Biophys Res Commun; 2014 Jul; 450(1):545-9. PubMed ID: 24924629
[TBL] [Abstract][Full Text] [Related]
18. Structure of the EphB6 receptor ectodomain.
Mason EO; Goldgur Y; Robev D; Freywald A; Nikolov DB; Himanen JP
PLoS One; 2021; 16(3):e0247335. PubMed ID: 33770085
[TBL] [Abstract][Full Text] [Related]
19. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.
Truitt L; Freywald T; DeCoteau J; Sharfe N; Freywald A
Cancer Res; 2010 Feb; 70(3):1141-53. PubMed ID: 20086179
[TBL] [Abstract][Full Text] [Related]
20. Comparative integromics on Eph family.
Katoh M; Katoh M
Int J Oncol; 2006 May; 28(5):1243-7. PubMed ID: 16596241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
